Euroapi SAS
PAR:EAPI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Euroapi SAS
PAR:EAPI
|
FR |
|
Longboard Pharmaceuticals Inc
NASDAQ:LBPH
|
US |
|
SOL SpA
MIL:SOL
|
IT |
|
M
|
Millbank Mining Corp
XTSX:MILL
|
CA |
|
I
|
Inter Pharma PCL
SET:IP
|
TH |
|
S
|
SCB X PCL
SET:SCB
|
TH |
|
Duketon Mining Ltd
F:DKN
|
AU |
|
Excite Technology Services Ltd
ASX:EXT
|
AU |
|
Philion SE
F:PH6
|
DE |
|
J
|
Jasmine Technology Solution PCL
SET:JTS
|
TH |
|
Vango Mining Ltd
ASX:VAN
|
AU |
|
I
|
Initiator Pharma A/S
STO:INIT
|
DK |
|
G
|
GEVORKYAN as
PSE:GEV
|
SK |
|
L
|
LPKF Laser & Electronics SE
XMUN:LPK
|
DE |
Wall St Price Targets
EAPI Price Targets Summary
Euroapi SAS
According to Wall Street analysts, the average 1-year price target for EAPI is 1.377 EUR with a low forecast of 0.808 EUR and a high forecast of 1.785 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EAPI's stock price target?
Price Target
1.377
EUR
According to Wall Street analysts, the average 1-year price target for EAPI is 1.377 EUR with a low forecast of 0.808 EUR and a high forecast of 1.785 EUR.
What is the Revenue forecast for Euroapi SAS?
Projected CAGR
1%
Over the last 5 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 4 years is 1%.
What is the Gross Profit forecast for Euroapi SAS?
Projected CAGR
-3%
Over the last 5 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 3 years is -3%.
What is the Operating Income forecast for Euroapi SAS?
Projected CAGR
112%
The compound annual growth rate for Operating Income over the next 3 years is 112%.
